Literature DB >> 35866711

Development of Parkinson Disease and Its Relationship with Incidentally Discovered White Matter Disease and Covert Brain Infarction in a Real-World Cohort.

David M Kent1, Lester Y Leung2, Eric J Puttock3, Andy Y Wang1, Patrick H Luetmer4, David F Kallmes4, Jason Nelson1, Sunyang Fu5, Chengyi Zheng3, Ellen M Vickery1, Hongfang Liu5, Alastair J Noyce6,7, Wansu Chen3.   

Abstract

OBJECTIVE: This study aimed to examine the relationship between covert cerebrovascular disease, comprised of covert brain infarction and white matter disease, discovered incidentally in routine care, and subsequent Parkinson disease.
METHODS: Patients were ≥50 years and received neuroimaging for non-stroke indications in the Kaiser Permanente Southern California system from 2009 to 2019. Natural language processing identified incidentally discovered covert brain infarction and white matter disease and classified white matter disease severity. The Parkinson disease outcome was defined as 2 ICD diagnosis codes.
RESULTS: 230,062 patients were included (median follow-up 3.72 years). A total of 1,941 Parkinson disease cases were identified (median time-to-event 2.35 years). Natural language processing identified covert cerebrovascular disease in 70,592 (30.7%) patients, 10,622 (4.6%) with covert brain infarction and 65,814 (28.6%) with white matter disease. After adjustment for known risk factors, white matter disease was associated with Parkinson disease (hazard ratio 1.67 [95%CI, 1.44, 1.93] for patients <70 years and 1.33 [1.18, 1.50] for those ≥70 years). Greater severity of white matter disease was associated with increased incidence of Parkinson disease(/1,000 person-years), from 1.52 (1.43, 1.61) in patients without white matter disease to 4.90 (3.86, 6.13) in those with severe disease. Findings were robust when more specific definitions of Parkinson disease were used. Covert brain infarction was not associated with Parkinson disease (adjusted hazard ratio = 1.05 [0.88, 1.24]).
INTERPRETATION: Incidentally discovered white matter disease was associated with subsequent Parkinson disease, an association strengthened with younger age and increased white matter disease severity. Incidentally discovered covert brain infarction did not appear to be associated with subsequent Parkinson disease. ANN NEUROL 2022;92:620-630.
© 2022 American Neurological Association.

Entities:  

Mesh:

Year:  2022        PMID: 35866711      PMCID: PMC9489676          DOI: 10.1002/ana.26458

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   11.274


  46 in total

Review 1.  MDS research criteria for prodromal Parkinson's disease.

Authors:  Daniela Berg; Ronald B Postuma; Charles H Adler; Bastiaan R Bloem; Piu Chan; Bruno Dubois; Thomas Gasser; Christopher G Goetz; Glenda Halliday; Lawrence Joseph; Anthony E Lang; Inga Liepelt-Scarfone; Irene Litvan; Kenneth Marek; José Obeso; Wolfgang Oertel; C Warren Olanow; Werner Poewe; Matthew Stern; Günther Deuschl
Journal:  Mov Disord       Date:  2015-10       Impact factor: 10.338

Review 2.  White matter lesions in Parkinson disease.

Authors:  Nicolaas I Bohnen; Roger L Albin
Journal:  Nat Rev Neurol       Date:  2011-02-22       Impact factor: 42.937

3.  The effects of striatal silent lacunar infarction on the substantia nigra and movement disorders in Parkinson's disease: A follow-up study.

Authors:  Guohua Zhang; Chengguo Zhang; Yuhu Zhang; Yukai Wang; Kun Nie; Bin Zhang; Haiqun Xie; Jiancong Lu; Lijuan Wang
Journal:  Parkinsonism Relat Disord       Date:  2017-06-27       Impact factor: 4.891

4.  Association of Silent Cerebrovascular Disease Identified Using Natural Language Processing and Future Ischemic Stroke.

Authors:  David M Kent; Lester Y Leung; Yichen Zhou; Patrick H Luetmer; David F Kallmes; Jason Nelson; Sunyang Fu; Chengyi Zheng; Hongfang Liu; Wansu Chen
Journal:  Neurology       Date:  2021-08-10       Impact factor: 11.800

5.  Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population.

Authors:  Cristina Simonet; Jonathan Bestwick; Mark Jitlal; Sheena Waters; Aaron Ben-Joseph; Charles R Marshall; Ruth Dobson; Soha Marrium; John Robson; Benjamin M Jacobs; Daniel Belete; Andrew J Lees; Gavin Giovannoni; Jack Cuzick; Anette Schrag; Alastair J Noyce
Journal:  JAMA Neurol       Date:  2022-04-01       Impact factor: 29.907

Review 6.  Clinical concept extraction: A methodology review.

Authors:  Sunyang Fu; David Chen; Huan He; Sijia Liu; Sungrim Moon; Kevin J Peterson; Feichen Shen; Liwei Wang; Yanshan Wang; Andrew Wen; Yiqing Zhao; Sunghwan Sohn; Hongfang Liu
Journal:  J Biomed Inform       Date:  2020-08-06       Impact factor: 6.317

7.  Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity.

Authors:  J G van Dijk; J Haan; K Zwinderman; B Kremer; B J van Hilten; R A Roos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-10       Impact factor: 10.154

8.  Diet pattern and prodromal features of Parkinson disease.

Authors:  Samantha Molsberry; Kjetil Bjornevik; Katherine C Hughes; Brian Healy; Michael Schwarzschild; Alberto Ascherio
Journal:  Neurology       Date:  2020-08-19       Impact factor: 9.910

9.  Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.

Authors:  Ga Eun Nam; Seon Mee Kim; Kyungdo Han; Nan Hee Kim; Hye Soo Chung; Jin Wook Kim; Byoungduck Han; Sung Jung Cho; Ji Hee Yu; Yong Gyu Park; Kyung Mook Choi
Journal:  PLoS Med       Date:  2018-08-21       Impact factor: 11.069

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.